Enliven Therapeutics ELVN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.34B.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's market capitalization?
- Enliven Therapeutics (ELVN) reported market capitalization of $2.34B in Q1 2026.
- How has Enliven Therapeutics's market capitalization changed year-over-year?
- Enliven Therapeutics's market capitalization increased by 143.1% year-over-year, from $964.41M to $2.34B.
- What is the long-term trend for Enliven Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Enliven Therapeutics's market capitalization has grown at a 18.7% compound annual growth rate (CAGR), from $387.58M to $913.95M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.